Image
|
Figure Caption
Fig. 9 Oxytocin receptor agonist increases ERK1/2 phosphorylation. The compound WAY-267464 did not impact AKT phosphorylation (a), but when used at a dosage of 50??M, it was found to enhance ERK1/2 phosphorylation (b). Data were analysed using a t-test (a: 100??M, b: 50??M). Mann?Whitney test was used for datasets that failed normality testing or had significantly different variances (a: 50??M, b: 100??M). The confidence limit of *p?
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ J. Psychopharmacol. (Oxford)